FindTrial
Sign In

Community based screening and treatment of Diabetes in India

Innovative M-health led Participatory Approach to Comprehensive Screening and Treatment of Diabetes: IMPACT Diabetes - IMPACT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031619
Enrollment
1600
Registered
2021-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Screening for Diabetes and confirmed Diabetes Mellitus Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Mobile based software with Clinical Decision Support: Mobile based software with Clinical Decision Support to Screen and manage of diabetes Time Duration would be nine months Control In

Sponsors

European Foundation for Study of Diabetes
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Willing to Consent and agree to follow up for upto 6 months

Exclusion criteria

Exclusion criteria: Not willing to stay in the study area for the duration of the study

Design outcomes

Primary

MeasureTime frame
Confirmed Diagnosis of Diabetes Mellitus, through fasting blood glucose and HBA1c Diagnosis of Diabetes MellitusTimepoint: Baseline and 12 months—

Secondary

MeasureTime frame
Management of Diabetes Mellitus and Evaluation for complications of DM, Treatment initiated and Glycemic Control achievedTimepoint: 6 months 9 months—

Countries

India

Contacts

Public ContactDr Oommen John

The George Institute for Global Health

ojohn@georgeinstitute.org.in911141588091

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026